DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
about
DNA methyltransferases and their roles in tumorigenesis.Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.
P2860
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
@en
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
@nl
type
label
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
@en
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
@nl
prefLabel
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
@en
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
@nl
P2093
P2860
P1476
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
@en
P2093
Jian-Qing Mi
Jun-Min Li
Sai-Juan Chen
Xiao-Jing Yan
Xue-Qiu Lin
P2860
P2888
P356
10.1186/S13045-016-0337-3
P577
2016-10-10T00:00:00Z
P6179
1005539773